ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

September 23, 1994